Healthcare

Why Did BriaCells Stock Skyrocket 155% Today?
June 03, 2021 10:05 AM AEST| By Team Kalkine MediaSummary Biotechnology company BriaCells (NASDAQ:BCTX) has reported that its immunotherapy treatment proved effective in breast cancer patients. It said that one of its patients survived 21 more months after receiving the treatment. The stock j.....

Nabriva & Protagenic: Two Pharma Stocks On Investors’ Radar
June 02, 2021 12:40 PM AEST| By Team Kalkine MediaSummary Nabriva plans to market its new pneumonia drug Lefamulin, jointly developed with China’s Sinnovant Sciences, as XENLETA in the US. Lefamulin’s phase-three clinical trial, conducted among 150 Chinese adults, has shown m.....

3 Trending Pharmacy Retail Stocks: CVS, Walgreens, Rite Aid
May 28, 2021 11:44 AM AEST| By Kiran MuraliSummary CVS Pharmacy operates over 9,900 retail locations. Walgreens offers same-day delivery with Instacart. Rite Aid operates 2,500 retail pharmacies in the U.S. Stocks of CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance, Inc. (NAS.....

Pieris Stock Rallies On Collaboration With Genentech
May 26, 2021 04:49 AM AEST| By Kiran MuraliSummary Pieris will collaborate with Genentech in respiratory and ophthalmology therapies. The biotechnology company will get an upfront payment of US$20 million in the deal. Pieris is also developing inhaled treatments for respiratory disease.....
.jpg)
Why Iovance (NASDAQ: IOVA) Stock Surged Today?
May 21, 2021 05:44 AM AEST| By Team Kalkine MediaSummary The stock boost comes after Iovance revealed that its new cancer drug showed positive results. Iovance can apply for a biologics license, which may happen in 2022, after FDA approval. The company develops treatment for patients with tu.....

Agenus Stock Up On US$1.56 Bn Licensing Deal
May 20, 2021 12:32 PM AEST| By Team Kalkine MediaThe stock of Agenus Inc (NYSE: AGEN) was up 5% at the market close on Wednesday, a day after it sealed a US$1.36 billion licensing deal with Bristol Myers Squibb (NYSE:BMY). Agenus, a biotechnology pharmaceuticals company, will receive U.....

Why CVS Health (NYSE: CVS) Is On Investors’ Radar This Week?
May 20, 2021 04:46 AM AEST| By Team Kalkine MediaSummary The stock of CVS Health hit a 52-week high of US$89.64 on Tuesday. Shawn Guertin to replace Eva Boratto to become the company’s new finance chief. CVS Health also reaffirmed its recently upgraded outlook for full-year 2021 earnin.....

Clover Health & Onconova Therapeutics: Two Rising Healthcare Stocks
May 18, 2021 04:13 AM AEST| By Team Kalkine MediaSummary Clover Health posted record revenue growth of US$200.3 million in Q1 of 2021. The stock of Onconova jumped 13.82% from its previous close to US$0.5987 at 11:50 am ET on May 17, ahead of its quarterly earnings report. Technology-based h.....

BioNTech Stock Jumps 10% After Strong Earnings Report
May 11, 2021 10:18 AM AEST| By Team Kalkine MediaSummary German biotechnology firm BioNTech’s revenues rose to €2.05 billion (US$2.49 billion) in the first quarter of 2021, compared to €27.7 million in the year-ago period. The stock gained more than 310% in the past 12 months,.....

Why These Three Penny Health Stocks Skyrocket Today?
May 05, 2021 05:20 AM AEST| By Team Kalkine MediaSummary Cocrystal stock (NASDAQ: COCP) jumped over 147% to US$3.07 at 12:21 pm ET on Tuesday, May 4. BioLineRx stock (NASDAQ:BLRX) soared over 68% to US$5.35 at 1:20 pm ET. Precipio stock (NASDAQ:PRPO) surged 15.52% to US$5.7181 at 2:47 pm ET......

Will These Three Healthcare Stocks Double In 2021?
May 04, 2021 05:35 AM AEST| By Team Kalkine MediaThe pandemic has triggered a flurry of activities in the pharmaceutical sector as companies rush to develop drugs to combat the virus. Following the early stage of drug development, companies are coming up with new medicines that are proving effect.....

Five Healthcare Stocks That May Benefit From Biden’s Drug Policy
April 29, 2021 03:19 AM AEST| By Team Kalkine MediaSummary President Biden’s new drug policy gets huge support from lawmakers, cutting across political lines. The policy allows the export of essential medicines and raw materials to friendly countries. US drugmakers are expected to receiv.....

2 COVID Vaccine Stocks to Watch In 2021
April 10, 2021 09:52 AM AEST| By Team Kalkine MediaSource:solarseven, Shutterstock Summary Moderna anticipates US$18.4 billion in sales from its COVID-19 vaccines in 2021. Pfizer forecasts COVID-19 vaccine revenue in 2021 to hit US$15 billion. Moderna’s stock skyrocketed over 430 percen...